Cargando…
A systematic review of non-standard dosing of oral anticancer therapies
BACKGROUND: The use of oral systemic anticancer therapies (SACT) has increased and led to improved cancer survival outcomes, particularly with the introduction of small molecule targeted agents and immunomodulators. Oral targeted SACT are, however, associated with toxicities, which might result in r...
Autores principales: | Djebbari, Faouzi, Stoner, Nicola, Lavender, Verna Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249819/ https://www.ncbi.nlm.nih.gov/pubmed/30466406 http://dx.doi.org/10.1186/s12885-018-5066-2 |
Ejemplares similares
-
Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol
por: Djebbari, Faouzi, et al.
Publicado: (2017) -
Clinical outcomes of bortezomib-based therapy in myeloma
por: Djebbari, Faouzi, et al.
Publicado: (2018) -
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review
por: Eyre, Toby A., et al.
Publicado: (2020) -
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care
por: Djebbari, Faouzi, et al.
Publicado: (2020) -
Oral Mucositis Induced By Anticancer Therapies
por: Al-Ansari, Sali, et al.
Publicado: (2015)